Joshua Budhu, Neuro-Oncologist at Memorial Sloan Kettering Cancer Center, shared on LinkedIn:
“Still recovering from Society for Neuro-Oncology Annual Meeting, SNO 2026!
What a great meeting filled with incredible research, advocacy, and progress in the CNS tumor space.
Always wonderful to reconnect with colleagues, meet future leaders in the field, and see the exciting work being done across neuro-oncology!
It was especially rewarding to see our Weill Cornell Medicine Dept. of Neurology resident Devon Riegel, and Memorial Sloan Kettering Cancer Center neuro-oncology fellow Michael Perez present our work!
I was also proud to serve as a track chair and moderate a session on telehealth, decentralization, and access to clinical trials, highlighting some of our work on financial toxicity and barriers to care.
One of the best parts of SNO is celebrating the next generation of neuro-oncology leaders!
It was a privilege to recognize this year’s Annual Meeting Travel Scholarship recipients and Future Leaders Program cohort.
Such impressive groups, and I’m so glad to see SNO continuing to invest in mentorship, leadership development, and the future of our field.
A huge thank you to the SNO staff and leadership for their hard work in making this meeting possible and for their continued commitment to advancing our field and supporting the next generation!
Already looking forward to next year!”

You can also read:
Walid Kamoun: Strategies to Improve Neuro-Oncology Clinical Trial Success at SNO 2026․
Zouina Sarfraz: Presenting New Studies on Melanoma and Lung Cancer Brain Metastases at SNO 2026․
Arnaud Lallouette at SNO 2026: What Comes Next for Brain Tumor Research․